RGNX
REGENXBIO Inc. · Healthcare · Market cap $563.1M
Insiders bought $231K net in the last 90 days ·1 seller, 1 buyer· 3 of 3 sales under Rule 10b5-1 plans· latest Form 4 filed Aug 27, 2026
Insider Buying
$949K
reported purchases (SEC code P)
Insider Selling
$1.3M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Sep 3, 2026
Ciongoli Gregory Austin
REGENXBIO Inc. (RGNX) has 33 SEC Form 4 filings (41 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Sep 3, 2026.
Inside the rolling window, 3 insiders at REGENXBIO Inc. reported 2 open-market purchases totaling $949K and 7 open-market sales totaling $1.3M. The most active filer is Chief Medical Officer PAKOLA STEVE with 5 filings. The most recent open-market filing is a purchase of 49,196 shares by Director Ciongoli Gregory Austin, dated Aug 26, 2026, worth $450K.
- Industry:Biotechnology
- CEO:Curran Simpson
- Employees:371
- HQ:Rockville, MD, US
- IPO:2015-09-17
| Source | |||||||
|---|---|---|---|---|---|---|---|
Ciongoli Gregory AustinFirst filing | Director | Purchase | 49,196 | $450K | Aug 27 | -9.0% | SEC ↗ |
Ciongoli Gregory AustinFirst filing | Director | Purchase | 53,407 | $500K | Aug 27 | -9.0% | SEC ↗ |
| Chief Medical Officer | Sale | 2,161 | $29K | Jul 6 | -42.5% | SEC ↗ | |
| Chief Medical Officer | Sale | 19,608 | $216K | Jul 1 | -34.8% | SEC ↗ | |
| Chief Medical Officer | Sale | 36,725 | $472K | Jul 1 | -34.8% | SEC ↗ | |
| Chief Medical Officer | Sale | 15,309 | $169K | May 13 | -15.0% | SEC ↗ | |
PAKOLA STEVEFirst filing | Chief Medical Officer | Sale | 5,124 | $53K | Mar 12 | -6.1% | SEC ↗ |
| Chief Executive Officer | Sale | 20,811 | $263K | Oct 10 | -21.9% | SEC ↗ | |
Simpson CurranFirst filing | Chief Executive Officer | Sale | 7,624 | $76K | Oct 1 | -12.7% | SEC ↗ |
Congress trading RGNX 2 all-time
- DRep. Peter WelchOther$1,001 - $15,0002019-11-08
- DRep. Peter WelchPurchase$1,001 - $15,0002019-10-22
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does RGNX have?
REGENXBIO Inc. (RGNX) has 33 SEC Form 4 filings (41 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Sep 3, 2026.
When was the most recent SEC Form 4 filing for RGNX?
The most recent Form 4 filing for RGNX on Tracefour is dated Sep 3, 2026.
Who is the most active insider at RGNX?
The most active SEC Form 4 filer at RGNX in the rolling window is Chief Medical Officer PAKOLA STEVE, with 5 filings.
What is the net insider flow at RGNX over the last 6 months?
Over the trailing 180 days, insiders at RGNX have net bought $9K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at RGNX in the current window?
Inside the rolling window, insiders at RGNX bought $949K and sold $1.3M based on SEC Form 4 filings.
Can I get alerts for RGNX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at REGENXBIO Inc. (RGNX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
REGENXBIO Inc. is in the Healthcare sector.